Department of Critical Care Units, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Front Immunol. 2023 Feb 7;14:1099468. doi: 10.3389/fimmu.2023.1099468. eCollection 2023.
Immunosuppressed patients can contract parvovirus B19, and some may experience hemophagocytic lymphohistiocytosis (HLH). Herein, we describe the first report of hemophagocytic lymphohistiocytosis in a heart-lung transplant patient with concomitant parvovirus B19 infection. The patient was treated with intravenous immune globulin (IVIG) and the features of HLH were remission. This instance emphasizes the significance of parvovirus B19 monitoring in transplant patients with anemia; if HLH complicates the situation, IVIG may be an adequate remedy. Finally, a summary of the development in diagnosing and managing parvovirus B19 infection complicated by HLH is provided.
免疫抑制的患者可能会感染细小病毒 B19,有些患者可能会出现噬血细胞性淋巴组织细胞增生症(HLH)。本文报道了首例心脏-肺移植患者合并细小病毒 B19 感染发生噬血细胞性淋巴组织细胞增生症的病例。该患者接受了静脉注射免疫球蛋白(IVIG)治疗,HLH 的特征得到了缓解。该病例强调了在发生贫血的移植患者中监测细小病毒 B19 的重要性;如果 HLH 使病情复杂化,IVIG 可能是一种有效的治疗方法。最后,提供了一份关于诊断和管理合并 HLH 的细小病毒 B19 感染的进展总结。